Report cover image

Continuous Glucose Monitoring (CGM) Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Countries, Company Analysis

Publisher Renub Research
Published Sep 01, 2022
Length 300 Pages
SKU # RNBR17403814

Description

Continuous Glucose Monitoring (CGM) Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Countries, Company Analysis

According to Renub Research, Continuous Glucose Monitoring Market is estimated to reach US$ 8.48 Billion by 2027. One of the most recent technical evolutions in diabetes management is continuous glucose monitoring (CGM). In brief, a CGM system is a form of glucose monitoring device that works by inserting a biosensor either transcutaneously or subcutaneously. Furthermore, the embedded sensor detects glucose levels in interstitial fluid or blood. It communicates the data to a receiver/monitor for display. Due to their numerous advantages over traditional glucose monitoring devices, these systems play an essential role in diabetes care. Unlike traditional glucose monitors, these devices allow for continuous glucose monitoring, which is critical for avoiding diabetic complications.

Global Continuous Glucose Monitoring Market Size Is Expanding with a CAGR Of 6.60% During 2021-2027:

The spike in the geriatric population and the increasing prevalence of diabetes have been essential factors driving the CGM market's expansion over the years worldwide. Furthermore, as the number of diabetic cases rises, the market for continuous glucose monitoring systems is predicted to grow and expand, attracting and compelling many industry participants to develop innovative products or product line extensions. Moreover, substantial growth potential in undeveloped areas is expected to generate significant profit opportunities for manufacturers during the anticipated period. However, a lack of proper funding for devices is a substantial impediment to their widespread adoption.

COVID-19 Impact on Continuous Glucose Monitoring Industry:

According to the World Health Organization (WHO), the number of people with type 2 diabetes has been rising in most nations, according to the World Health Organization (WHO). Furthermore, according to our findings, the COVID-19 epidemic has increased the necessity of evaluating the feasibility of continuous glucose monitoring (CGM) in hospitals to preserve personal protective equipment (PPE) and restrict exposure to health care workers. As a result, the Continuous Glucose Monitoring Market has grown even during the epidemic. Moreover, as per our analysis, Global Continuous Glucose Monitoring Market reached US$. 5.78 Billion in 2021.

Segment Analysis in Continuous Glucose Monitoring Market:

The Global Continuous Glucose Monitoring Market is studied in the United States, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, United Kingdom, and Japan. Further, the market in detail is categorized based on Diabetes Population (Type 1 and Type 2, CGM Market, CGM Market by Components, Glucose Sensor Market, CGM Transmitter Market, CGM User, and CGM Reimbursement.

Competitive Landscape:

The Continuous Glucose Monitoring (CGM) Market is highly competitive, with only a few companies competing. Abbott Laboratories, Roche, Tandem Diabetes Care, Dexcom Inc, and Senseonics are among the important players profiled in our analysis. These firms control a significant portion of the global market. In addition, they are continually entering new markets to develop new revenue streams and strengthen existing ones. These market actors' actions will create a competitive marketplace, forcing enterprises to experiment with the latest technology to maintain originality in their products. Companies are also working together to improve their technical knowledge and shorten the product development cycle.

Renub Research latest report “Continuous Glucose Monitoring (CGM) Market, Global Forecast, By Components (Glucose Sensor Market and CGM Transmitter Market), Countries (United States, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, United Kingdom and Japan), Country Insights (Diabetes Population (Type 1 and Type 2), CGM Market, CGM Market by Components, Glucose Sensor Market, CGM Transmitter Market, CGM User and CGM Reimbursement), Companies (Abbott Laboratories, Roche, Tandem Diabetes Care, Dexcom Inc, and Senseonics)” provides a detailed analysis of Continuous Glucose Monitoring (CGM) Industry.

By Components – the market has been studied based on 2 viewpoints:

1. Glucose Sensor Market
2. CGM Transmitter Market

By Countries – the market has been studied for 11 countries:

1. United States
2. Canada
3. Germany
4. Australia
5. France
6. Netherlands
7. Switzerland
8. Sweden
9. Israel
10. United Kingdom
11. Japan

The above-mentioned countries have been studied from 7 viewpoints:

1. Diabetes Population

• Type 1
• Type 2

2. CGM Market
3. CGM Market by Components
4. Glucose Sensor Market
5. CGM Transmitter Market
6. CGM User
7. CGM Reimbursement

Company Insights:

• Overview
• Recent Development
• Revenue

Companies Covered:

1. Abbott Laboratories
2. Roche
3. Tandem Diabetes Care
4. Dexcom Inc
5. Senseonics

Table of Contents

300 Pages
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global CGM Market and User Analysis
5.1 Market
5.2 User
6. By Components – Continuous Glucose Monitoring Market
6.1 Glucose Sensor Market
6.2 CGM Transmitter Market
7. Global CGM Market and CGM User Share Analysis
7.1 CGM Market Share
7.1.1 Glucose Sensor Market Share
7.1.2 CGM Transmitter Market Share
7.2 CGM User Share
8. Global CGM (Continuous Glucose Monitoring) Reimbursement Model
9. Abbott Freestyle Libre vs CGM (Continuous Glucose Monitoring)
10. United States
10.1 Diabetes Population
10.1.1 Type 1
10.1.2 Type 2
10.2 United States – CGM Market
10.2.1 United States - CGM Market by Components
10.2.1.1 Glucose Sensor Market
10.2.1.2 CGM Transmitter Market
10.3 United States – CGM User
10.4 CGM Reimbursement in United States
11. Canada
11.1 Diabetes Population
11.1.1 Type 1
11.1.2 Type 2
11.2 Canada – CGM Market
11.2.1 Canada - CGM Market by Components
11.2.1.1 Glucose Sensor Market
11.2.1.2 CGM Transmitter Market
11.3 Canada – CGM User
11.4 CGM Reimbursement in United States
12. Germany
12.1 Diabetes Population
12.1.1 Type 1
12.1.2 Type 2
12.2 Germany – CGM Market
12.2.1 Germany - CGM Market by Components
12.2.1.1 Glucose Sensor Market
12.2.1.2 CGM Transmitter Market
12.3 Germany – CGM User
12.4 CGM Reimbursement in United States
13. Australia
13.1 Diabetes Population
13.1.1 Type 1
13.1.2 Type 2
13.2 Australia – CGM Market
13.2.1 Australia - CGM Market by Components
13.2.1.1 Glucose Sensor Market
13.2.1.2 CGM Transmitter Market
13.3 Australia – CGM User
13.4 CGM Reimbursement in United States
14. France
14.1 Diabetes Population
14.1.1 Type 1
14.1.2 Type 2
14.2 France – CGM Market
14.2.1 France - CGM Market by Components
14.2.1.1 Glucose Sensor Market
14.2.1.2 CGM Transmitter Market
14.3 France – CGM User
14.4 CGM Reimbursement in United States
15. Netherlands
15.1 Diabetes Population
15.1.1 Type 1
15.1.2 Type 2
15.2 Netherlands – CGM Market
15.2.1 Netherlands - CGM Market by Components
15.2.1.1 Glucose Sensor Market
15.2.1.2 CGM Transmitter Market
15.3 Netherlands – CGM User
15.4 CGM Reimbursement in United States
16. Switzerland
16.1 Diabetes Population
16.1.1 Type 1
16.1.2 Type 2
16.2 Switzerland – CGM Market
16.2.1 Switzerland - CGM Market by Components
16.2.1.1 Glucose Sensor Market
16.2.1.2 CGM Transmitter Market
16.3 Switzerland – CGM User
16.4 CGM Reimbursement in United States
17. Sweden
17.1 Diabetes Population
17.1.1 Type 1
17.1.2 Type 2
17.2 Sweden – CGM Market
17.2.1 Sweden - CGM Market by Components
17.2.1.1 Glucose Sensor Market
17.2.1.2 CGM Transmitter Market
17.3 Sweden – CGM User
17.4 CGM Reimbursement in United States
18. Israel
18.1 Diabetes Population
18.1.1 Type 1
18.1.2 Type 2
18.2 Israel – CGM Market
18.2.1 Israel - CGM Market by Components
18.2.1.1 Glucose Sensor Market
18.2.1.2 CGM Transmitter Market
18.3 Israel – CGM User
18.4 CGM Reimbursement in United States
19. United Kingdom
19.1 Diabetes Population
19.1.1 Type 1
19.1.2 Type 2
19.2 United Kingdom – CGM Market
19.2.1 United Kingdom - CGM Market by Components
19.2.1.1 Glucose Sensor Market
19.2.1.2 CGM Transmitter Market
19.3 United Kingdom – CGM User
19.4 CGM Reimbursement in United States
20. Japan
20.1 Diabetes Population
20.1.1 Type 1
20.1.2 Type 2
20.2 Japan – CGM Market
20.2.1 Japan - CGM Market by Components
20.2.1.1 Glucose Sensor Market
20.2.1.2 CGM Transmitter Market
20.3 Japan – CGM User
20.4 CGM Reimbursement in United States
21 Company Analysis
21.1 Abbott Laboratories
21.1.1 Overview
21.1.2 Recent Development
21.1.3 Revenue
21.2 Roche
21.2.1 Overview
21.2.2 Recent Development
21.2.3 Revenue
21.3 Tandem Diabetes Care
21.3.1 Overview
21.3.2 Recent Development
21.3.3 Revenue
21.4 Dexcom Inc
21.4.1 Overview
21.4.2 Recent Development
21.4.3 Revenue
21.5 Senseonics
21.5.1 Overview
21.5.2 Recent Development
21.5.3 Revenue
List of Figures:
Figure-01: Global – Continuous Glucose Monitoring Market (Million US$), 2017 – 2021
Figure-02: Global – Forecast for Continuous Glucose Monitoring Market (Million US$), 2022 – 2027
Figure-03: Global – Continuous Glucose Monitoring User Volume (Thousand), 2017 – 2021
Figure-04: Global – Forecast for Continuous Glucose Monitoring User Volume (Thousand), 2022 – 2027
Figure-05: Global – Glucose Sensor Market (Million US$), 2017 – 2021
Figure-06: Global – Forecast for Glucose Sensor Market (Million US$), 2022 – 2027
Figure-07: Global – CGM Transmitter Market (Million US$), 2017 – 2021
Figure-08: Global – Forecast for CGM Transmitter Market (Million US$), 2022 – 2027
Figure-09: United States – Diabetes Population Type 1 Volume (Thousand), 2017 – 2021
Figure-10: United States – Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 – 2027
Figure-11: United States – Diabetes Population Type 2 Volume (Thousand), 2017 – 2021
Figure-12: United States – Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 – 2027
Figure-13: United States – Glucose Sensor Market (Million US$), 2017 – 2021
Figure-14: United States – Forecast for Glucose Sensor Market (Million US$), 2022 – 2027
Figure-15: United States – CGM Transmitter Market (Million US$), 2017 – 2021
Figure-16: United States – Forecast for CGM Transmitter Market (Million US$), 2022 – 2027
Figure-17: United States – CGM User Volume (Number), 2017 – 2021
Figure-18: United States – Forecast for CGM User Volume (Number), 2022 – 2027
Figure-19: Canada – Diabetes Population Type 1 Volume (Thousand), 2017 – 2021
Figure-20: Canada – Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 – 2027
Figure-21: Canada – Diabetes Population Type 2 Volume (Thousand), 2017 – 2021
Figure-22: Canada – Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 – 2027
Figure-23: Canada – Glucose Sensor Market (Million US$), 2017 – 2021
Figure-24: Canada – Forecast for Glucose Sensor Market (Million US$), 2022 – 2027
Figure-25: Canada – CGM Transmitter Market (Million US$), 2017 – 2021
Figure-26: Canada – Forecast for CGM Transmitter Market (Million US$), 2022 – 2027
Figure-27: Canada – CGM User Volume (Number), 2017 – 2021
Figure-28: Canada – Forecast for CGM User Volume (Number), 2022 – 2027
Figure-29: Germany – Diabetes Population Type 1 Volume (Thousand), 2017 – 2021
Figure-30: Germany – Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 – 2027
Figure-31: Germany – Diabetes Population Type 2 Volume (Thousand), 2017 – 2021
Figure-32: Germany – Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 – 2027
Figure-33: Germany – Glucose Sensor Market (Million US$), 2017 – 2021
Figure-34: Germany – Forecast for Glucose Sensor Market (Million US$), 2022 – 2027
Figure-35: Germany – CGM Transmitter Market (Million US$), 2017 – 2021
Figure-36: Germany – Forecast for CGM Transmitter Market (Million US$), 2022 – 2027
Figure-37: Germany – CGM User Volume (Number), 2017 – 2021
Figure-38: Germany – Forecast for CGM User Volume (Number), 2022 – 2027
Figure-39: Australia – Diabetes Population Type 1 Volume (Thousand), 2017 – 2021
Figure-40: Australia – Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 – 2027
Figure-41: Australia – Diabetes Population Type 2 Volume (Thousand), 2017 – 2021
Figure-42: Australia – Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 – 2027
Figure-43: Australia – Glucose Sensor Market (Million US$), 2017 – 2021
Figure-44: Australia – Forecast for Glucose Sensor Market (Million US$), 2022 – 2027
Figure-45: Australia – CGM Transmitter Market (Million US$), 2017 – 2021
Figure-46: Australia – Forecast for CGM Transmitter Market (Million US$), 2022 – 2027
Figure-47: Australia – CGM User Volume (Number), 2017 – 2021
Figure-48: Australia – Forecast for CGM User Volume (Number), 2022 – 2027
Figure-49: France – Diabetes Population Type 1 Volume (Thousand), 2017 – 2021
Figure-50: France – Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 – 2027
Figure-51: France – Diabetes Population Type 2 Volume (Thousand), 2017 – 2021
Figure-52: France – Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 – 2027
Figure-53: France – Glucose Sensor Market (Million US$), 2017 – 2021
Figure-54: France – Forecast for Glucose Sensor Market (Million US$), 2022 – 2027
Figure-55: France – CGM Transmitter Market (Million US$), 2017 – 2021
Figure-57: France – Forecast for CGM Transmitter Market (Million US$), 2022 – 2027
Figure-56: France – CGM User Volume (Number), 2017 – 2021
Figure-58: France – Forecast for CGM User Volume (Number), 2022 – 2027
Figure-59: Netherlands – Diabetes Population Type 1 Volume (Thousand), 2017 – 2021
Figure-60: Netherlands – Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 – 2027
Figure-61: Netherlands – Diabetes Population Type 2 Volume (Thousand), 2017 – 2021
Figure-62: Netherlands – Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 – 2027
Figure-63: Netherlands – Glucose Sensor Market (Million US$), 2017 – 2021
Figure-64: Netherlands – Forecast for Glucose Sensor Market (Million US$), 2022 – 2027
Figure-65: Netherlands – CGM Transmitter Market (Million US$), 2017 – 2021
Figure-66: Netherlands – Forecast for CGM Transmitter Market (Million US$), 2022 – 2027
Figure-67: Netherlands – CGM User Volume (Number), 2017 – 2021
Figure-68: Netherlands – Forecast for CGM User Volume (Number), 2022 – 2027
Figure-69: Switzerland – Diabetes Population Type 1 Volume (Thousand), 2017 – 2021
Figure-70: Switzerland – Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 – 2027
Figure-71: Switzerland – Diabetes Population Type 2 Volume (Thousand), 2017 – 2021
Figure-72: Switzerland – Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 – 2027
Figure-73: Switzerland – Glucose Sensor Market (Million US$), 2017 – 2021
Figure-74: Switzerland – Forecast for Glucose Sensor Market (Million US$), 2022 – 2027
Figure-75: Switzerland – CGM Transmitter Market (Million US$), 2017 – 2021
Figure-76: Switzerland – Forecast for CGM Transmitter Market (Million US$), 2022 – 2027
Figure-77: Switzerland – CGM User Volume (Number), 2017 – 2021
Figure-78: Switzerland – Forecast for CGM User Volume (Number), 2022 – 2027
Figure-79: Sweden – Diabetes Population Type 1 Volume (Thousand), 2017 – 2021
Figure-80: Sweden – Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 – 2027
Figure-81: Sweden – Diabetes Population Type 2 Volume (Thousand), 2017 – 2021
Figure-82: Sweden – Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 – 2027
Figure-83: Sweden – Glucose Sensor Market (Million US$), 2017 – 2021
Figure-84: Sweden – Forecast for Glucose Sensor Market (Million US$), 2022 – 2027
Figure-85: Sweden – CGM Transmitter Market (Million US$), 2017 – 2021
Figure-86: Sweden – Forecast for CGM Transmitter Market (Million US$), 2022 – 2027
Figure-87: Sweden – CGM User Volume (Number), 2017 – 2021
Figure-88: Sweden – Forecast for CGM User Volume (Number), 2022 – 2027
Figure-89: Israel – Diabetes Population Type 1 Volume (Thousand), 2017 – 2021
Figure-90: Israel – Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 – 2027
Figure-91: Israel – Diabetes Population Type 2 Volume (Thousand), 2017 – 2021
Figure-92: Israel – Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 – 2027
Figure-93: Israel – Glucose Sensor Market (Million US$), 2017 – 2021
Figure-94: Israel – Forecast for Glucose Sensor Market (Million US$), 2022 – 2027
Figure-95: Israel – CGM Transmitter Market (Million US$), 2017 – 2021
Figure-96: Israel – Forecast for CGM Transmitter Market (Million US$), 2022 – 2027
Figure-97: Israel – CGM User Volume (Number), 2017 – 2021
Figure-98: Israel – Forecast for CGM User Volume (Number), 2022 – 2027
Figure-99: United Kingdom – Diabetes Population Type 1 Volume (Thousand), 2017 – 2021
Figure-100: United Kingdom – Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 – 2027
Figure-101: United Kingdom – Diabetes Population Type 2 Volume (Thousand), 2017 – 2021
Figure-102: United Kingdom – Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 – 2027
Figure-103: United Kingdom – Glucose Sensor Market (Million US$), 2017 – 2021
Figure-104: United Kingdom – Forecast for Glucose Sensor Market (Million US$), 2022 – 2027
Figure-105: United Kingdom – CGM Transmitter Market (Million US$), 2017 – 2021
Figure-106: United Kingdom – Forecast for CGM Transmitter Market (Million US$), 2022 – 2027
Figure-107: United Kingdom – CGM User Volume (Number), 2017 – 2021
Figure-108: United Kingdom – Forecast for CGM User Volume (Number), 2022 – 2027
Figure-109: Japan – Diabetes Population Type 1 Volume (Thousand), 2017 – 2021
Figure-110: Japan – Forecast for Diabetes Population Type 1 Volume (Thousand), 2022 – 2027
Figure-111: Japan – Diabetes Population Type 2 Volume (Thousand), 2017 – 2021
Figure-112: Japan – Forecast for Diabetes Population Type 2 Volume (Thousand), 2022 – 2027
Figure-113: Japan – Glucose Sensor Market (Million US$), 2017 – 2021
Figure-114: Japan – Forecast for Glucose Sensor Market (Million US$), 2022 – 2027
Figure-115: Japan – CGM Transmitter Market (Million US$), 2017 – 2021
Figure-116: Japan – Forecast for CGM Transmitter Market (Million US$), 2022 – 2027
Figure-117: Japan – CGM User Volume (Number), 2017 – 2021
Figure-118: Japan – Forecast for CGM User Volume (Number), 2022 – 2027
Figure-119: Abbott Laboratories – Global Revenue (Million US$), 2017 – 2021
Figure-120: Abbott Laboratories – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-121: Roche – Global Revenue (Million US$), 2017 – 2021
Figure-122: Roche – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-123: Tandem Diabetes Care – Global Revenue (Million US$), 2017 – 2021
Figure-124: Tandem Diabetes Care – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-125: Dexcom Inc – Global Revenue (Million US$), 2017 – 2021
Figure-126: Dexcom Inc – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-127: Senseonics – Global Revenue (Million US$), 2017 – 2021
Figure-128: Senseonics – Forecast for Global Revenue (Million US$), 2022 – 2027
List of Tables:
Table-01: Global – CGM Market Share by Countries (Percent), 2017 – 2021
Table-02: Global – Forecast for CGM Market Share by Countries (Percent), 2022 – 2027
Table-03: Global – Glucose Sensor Market Share by Countries (Percent), 2017 – 2021
Table-04: Global – Forecast for Glucose Sensor Market Share by Countries (Percent), 2022 – 2027
Table-05: Global – CGM Transmitter Market Share by Countries (Percent), 2017 – 2021
Table-06: Global – Forecast for CGM Transmitter Market Share by Countries (Percent), 2022 – 2027
Table-07: Global – CGM User Volume Share by Countries (Percent), 2017 – 2021
Table-08: Global – Forecast for CGM User Volume Share by Countries (Percent), 2022 – 2027

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us